ADIAL PHARMACEUTICALS, INC. - Form 4 Filing

On June 17, 2026, Wendy B. Young, a director at ADIAL PHARMACEUTICALS, INC., was granted a stock option to acquire 25,666 shares of Common Stock. The option was approved by the board of directors on June 11, 2026, and became effective after stockholder approval of an amendment to the Issuer's 2017 Equity Incentive Plan on September 17, 2026. A portion of the shares, 2,138, vested on the approval date, with the remaining 23,528 shares vesting in installments over 33 months starting October 12, 2026. The option has an exercise price of $2.98 and expires on June 12, 2036. This transaction is reported on a Form 4 filing.